Alterations of the tissue inhibitor of metalloproteinase-3 (TIMP3) gene in pancreatic adenocarcinomas
Tissue inhibitor of metalloproteinase-3 (TIMP3) antagonizes matrix metalloproteinase activity and can suppress tumor growth, angiogenesis, invasion, and metastases. In the present study, the involvement of TIMP3 in the tumorigenesis of 34 pancreatic adenocarcinomas was evaluated. Immunohistochemistr...
Saved in:
| Published in: | Pancreas Vol. 30; no. 2; pp. e40 - e45 |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
01-03-2005
|
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Tissue inhibitor of metalloproteinase-3 (TIMP3) antagonizes matrix metalloproteinase activity and can suppress tumor growth, angiogenesis, invasion, and metastases. In the present study, the involvement of TIMP3 in the tumorigenesis of 34 pancreatic adenocarcinomas was evaluated.
Immunohistochemistry, methylation-specific PCR, and RNA expression analysis (RT-PCR) of TIMP3 were performed in 34 resected and microdissected primary pancreatic adenocarcinomas.
Immunohistochemistry showed loss or strongly reduced protein expression in 17 of 34 pancreatic adenocarcinomas (50%) that corresponded to loss of TIMP3-RNA-expression. Promoter hypermethylation was identified in 2 of 34 tumors (6%). It was tumor specific and corresponded to a loss of TIMP3 protein expression. TIMP3 alterations did not correlate with any clinical feature such as tumor size or survival.
TIMP3 seems to play an important role in the tumorigenesis of primary pancreatic adenocarcinomas. In contrast to other tumors, hypermethylation seems not to be the key mechanism for the inactivation of TIMP3. Other methods of gene inactivation need to be identified. |
|---|---|
| AbstractList | Tissue inhibitor of metalloproteinase-3 (TIMP3) antagonizes matrix metalloproteinase activity and can suppress tumor growth, angiogenesis, invasion, and metastases. In the present study, the involvement of TIMP3 in the tumorigenesis of 34 pancreatic adenocarcinomas was evaluated.
Immunohistochemistry, methylation-specific PCR, and RNA expression analysis (RT-PCR) of TIMP3 were performed in 34 resected and microdissected primary pancreatic adenocarcinomas.
Immunohistochemistry showed loss or strongly reduced protein expression in 17 of 34 pancreatic adenocarcinomas (50%) that corresponded to loss of TIMP3-RNA-expression. Promoter hypermethylation was identified in 2 of 34 tumors (6%). It was tumor specific and corresponded to a loss of TIMP3 protein expression. TIMP3 alterations did not correlate with any clinical feature such as tumor size or survival.
TIMP3 seems to play an important role in the tumorigenesis of primary pancreatic adenocarcinomas. In contrast to other tumors, hypermethylation seems not to be the key mechanism for the inactivation of TIMP3. Other methods of gene inactivation need to be identified. OBJECTIVESTissue inhibitor of metalloproteinase-3 (TIMP3) antagonizes matrix metalloproteinase activity and can suppress tumor growth, angiogenesis, invasion, and metastases. In the present study, the involvement of TIMP3 in the tumorigenesis of 34 pancreatic adenocarcinomas was evaluated. METHODSImmunohistochemistry, methylation-specific PCR, and RNA expression analysis (RT-PCR) of TIMP3 were performed in 34 resected and microdissected primary pancreatic adenocarcinomas. RESULTSImmunohistochemistry showed loss or strongly reduced protein expression in 17 of 34 pancreatic adenocarcinomas (50%) that corresponded to loss of TIMP3-RNA-expression. Promoter hypermethylation was identified in 2 of 34 tumors (6%). It was tumor specific and corresponded to a loss of TIMP3 protein expression. TIMP3 alterations did not correlate with any clinical feature such as tumor size or survival. CONCLUSIONTIMP3 seems to play an important role in the tumorigenesis of primary pancreatic adenocarcinomas. In contrast to other tumors, hypermethylation seems not to be the key mechanism for the inactivation of TIMP3. Other methods of gene inactivation need to be identified. |
| Author | Nowak, Oxana Gerdes, Berthold Ramaswamy, Annette Bartsch, Detlef K Slater, Emily P Chaloupka, Brunhilde Celik, Ilhan Fendrich, Volker Heinmöller, Ernst |
| Author_xml | – sequence: 1 givenname: Volker surname: Fendrich fullname: Fendrich, Volker email: fendrich@med.uni-marburg.de organization: Department of Visceral-, Thoracic-, and Vascular Surgery, Philipps-University, Marburg, Germany. fendrich@med.uni-marburg.de – sequence: 2 givenname: Emily P surname: Slater fullname: Slater, Emily P – sequence: 3 givenname: Ernst surname: Heinmöller fullname: Heinmöller, Ernst – sequence: 4 givenname: Annette surname: Ramaswamy fullname: Ramaswamy, Annette – sequence: 5 givenname: Ilhan surname: Celik fullname: Celik, Ilhan – sequence: 6 givenname: Oxana surname: Nowak fullname: Nowak, Oxana – sequence: 7 givenname: Brunhilde surname: Chaloupka fullname: Chaloupka, Brunhilde – sequence: 8 givenname: Berthold surname: Gerdes fullname: Gerdes, Berthold – sequence: 9 givenname: Detlef K surname: Bartsch fullname: Bartsch, Detlef K |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15714128$$D View this record in MEDLINE/PubMed |
| BookMark | eNpFkE9r3DAQxUVJSTZ_vkIxPZTmYFfyyJbcWwhNG0hpD8lZjLWjRsWWtpL20G9fbbOQgWHg8d7M8DtnJyEGYuy94J3gk_rERbfusOO1xADQD93Yi6nvNL5hm6qMrdS9PmEbrvXQglDqjJ3n_LvaFQzTKTsTgxJS9HrD6GYplLD4GHITXVOeqSk-5z01Pjz72ZeYDvpKBZcl7lIs5ANmaqH5-Hj__SdcN78oHNzNDoNNVHfZBrcUosVkfYgr5kv21uGS6eo4L9jT3ZfH22_tw4-v97c3D60FDaWduHAw6RHn7TBZJOQAGkkNDu0snRO1kc898F47qUcFWy0npaVUIAdycME-vOytf_7ZUy5m9dnSsmCguM9mVBKmXkM1fn4x2hRzTuTMLvkV018juDlANlyYCtm8Qjb_IRuNNfzueGU_r7R9jR6pwj8MLXvu |
| CitedBy_id | crossref_primary_10_1007_s00534_005_1050_8 crossref_primary_10_1186_s40064_015_0950_6 crossref_primary_10_1089_ars_2011_4076 crossref_primary_10_1007_s11894_008_0030_y crossref_primary_10_1093_carcin_bgt319 crossref_primary_10_1007_s00441_020_03211_y crossref_primary_10_1097_MPA_0b013e3181630ffe crossref_primary_10_1007_s00261_009_9564_1 crossref_primary_10_1152_ajpgi_00010_2014 crossref_primary_10_1038_modpathol_2011_142 crossref_primary_10_1371_journal_pone_0159090 crossref_primary_10_1097_01_mog_0000239861_89209_5f crossref_primary_10_1182_blood_2011_08_376418 crossref_primary_10_1186_s12876_020_01268_1 crossref_primary_10_12677_WJCR_2013_31001 crossref_primary_10_2958_suizo_26_59 crossref_primary_10_2958_suizo_23_66 crossref_primary_10_1097_01_mog_0000174221_92708_50 crossref_primary_10_1007_s00270_008_9457_7 crossref_primary_10_1111_j_1572_0241_2006_00856_x crossref_primary_10_1007_s00535_010_0267_8 crossref_primary_10_1007_s00534_005_1049_1 crossref_primary_10_5812_ijem_56120 crossref_primary_10_1007_s10555_010_9253_0 crossref_primary_10_1016_j_ejca_2010_01_009 crossref_primary_10_1016_j_gene_2020_144700 crossref_primary_10_1007_s00261_014_0226_6 crossref_primary_10_2958_suizo_30_741 crossref_primary_10_1517_14728222_2010_504717 crossref_primary_10_1002_mc_20457 crossref_primary_10_1097_MPA_0b013e31817f76d8 crossref_primary_10_1177_17562848231192144 |
| Cites_doi | 10.1097/00000658-200201000-00007 10.1093/carcin/17.9.1805 10.1002/gcc.2870140306 10.1093/jnci/89.17.1260 10.1210/jc.2002-021027 10.1158/1078-0432.CCR-1157-03 10.1016/S0002-9440(10)64262-9 10.1001/archopht.118.1.85 10.3322/canjclin.50.1.7 10.1073/pnas.93.18.9821 10.1016/S0002-9440(10)64520-8 10.1139/o96-090 10.1093/jnci/88.10.680 10.1038/sj.bjc.6690217 10.1210/jcem.86.12.8089 10.1002/1096-9098(200008)74:4<243::AID-JSO1>3.0.CO;2-C |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
| DOI | 10.1097/01.mpa.0000153325.62192.8a |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1536-4828 |
| EndPage | e45 |
| ExternalDocumentID | 10_1097_01_mpa_0000153325_62192_8a 15714128 |
| Genre | Journal Article |
| GroupedDBID | --- .-D .55 .GJ .XZ .Z2 0R~ 123 4Q1 4Q2 4Q3 53G 5RE 5VS 8L- AAAAV AAHPQ AAIQE AAJCS AAMTA AARTV AASCR AAYEP ABASU ABBUW ABDIG ABJNI ABOCM ABVCZ ABXVJ ABZAD ACCJW ACDDN ACEWG ACGFO ACGFS ACILI ACWDW ACWRI ACXJB ACXNZ ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFDTB AFEXH AFUWQ AHQNM AHRYX AHVBC AINUH AJIOK AJNWD AJNYG AJZMW ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AWKKM BQLVK BS7 C45 CGR CS3 CUY CVF DIWNM DU5 DUNZO E.X EBS ECM EEVPB EIF EJD EX3 F2K F2L F5P FCALG FL- GNXGY GQDEL H0~ HLJTE HZ~ IKREB IN~ JF9 JG8 JK3 JK8 K8S KD2 KMI L-C N9A NPM N~M O9- OAG OAH OCUKA ODA ODMTH OHYEH OJAPA OL1 OLG OLV OLW OLZ OPUJH ORVUJ OUVQU OVD OVDNE OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P R58 RLZ S4R S4S T8P TEORI TSPGW V2I VVN W3M WOQ WOW X3V X3W X7M XXN XYM YFH ZFV ZXP ZZMQN AAYXX CITATION 7X8 |
| ID | FETCH-LOGICAL-c383t-901f3986abd59caea0338ae75facb4ff14ffa0b23028f48673d84978447345ef3 |
| ISSN | 0885-3177 |
| IngestDate | Fri Aug 16 22:14:34 EDT 2024 Fri Aug 23 02:09:38 EDT 2024 Sat Sep 28 08:38:20 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c383t-901f3986abd59caea0338ae75facb4ff14ffa0b23028f48673d84978447345ef3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 15714128 |
| PQID | 67439283 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_67439283 crossref_primary_10_1097_01_mpa_0000153325_62192_8a pubmed_primary_15714128 |
| PublicationCentury | 2000 |
| PublicationDate | 2005-03-01 |
| PublicationDateYYYYMMDD | 2005-03-01 |
| PublicationDate_xml | – month: 03 year: 2005 text: 2005-03-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Pancreas |
| PublicationTitleAlternate | Pancreas |
| PublicationYear | 2005 |
| References | Rozenblum (R3-20-20210212) 1997; 57 Gerdes (R6-20-20210212) 2002; 235 Bachman (R12-20-20210212) 1999; 59 Ueki (R14-20-20210212) 2000; 60 Wild (R22-20-20210212) 2002; 147 Wild (R13-20-20210212) 2003; 88 Gomez (R7-20-20210212) 1997; 74 Zochbauer-Muller (R26-20-20210212) 2001; 61 Anand-Apte (R18-20-20210212) 1997; 38 Bian (R19-20-20210212) 1996; 17 Chambers (R17-20-20210212) 1997; 89 Bartsch (R4-20-20210212) 1995; 14 Wild (R21-20-20210212) 2001; 86 Sessa (R28-20-20210212) 1998; 42 Felbor (R24-20-20210212) 1997; 60 Chambers (R9-20-20210212) 1997; 89 Goggins (R2-20-20210212) 2000; 74 Ayyagari (R25-20-20210212) 2000; 118 Greenlee (R1-20-20210212) 2000; 50 Anand-Apte (R8-20-20210212) 1996; 74 Hruban (R27-20-20210212) 1993; 143 Lee (R20-20-20210212) 2002; 161 Bartsch (R5-20-20210212) 1996; 88 Baker (R11-20-20210212) 1999; 79 Herman (R15-20-20210212) 1996; 93 Jones (R23-20-20210212) 2004; 10 Ahonen (R10-20-20210212) 1998; 58 Heinmoller (R16-20-20210212) 2000; 157 |
| References_xml | – volume: 147 start-page: 1 year: 2002 ident: R22-20-20210212 article-title: Chromosome 22q in pancreatic endocrine tumors: identification of a homozygous deletion and potential prognostic associations of allelic deletions. publication-title: Eur J Endocrinol contributor: fullname: Wild – volume: 38 start-page: 817 year: 1997 ident: R18-20-20210212 article-title: Inhibition of angiogenesis by tissue inhibitor of metalloproteinases-3. publication-title: Invest Ophthalmol Vis Sci contributor: fullname: Anand-Apte – volume: 235 start-page: 51 year: 2002 ident: R6-20-20210212 article-title: p16INK4a is a prognostic marker in resected ductal pancreatic cancer: an analysis of p16INK4a, p53, MDM2, and Rb. publication-title: Ann Surg doi: 10.1097/00000658-200201000-00007 contributor: fullname: Gerdes – volume: 60 start-page: 1835 year: 2000 ident: R14-20-20210212 article-title: Hypermethylation of multiple genes in pancreatic adenocarcinoma. publication-title: Cancer Res contributor: fullname: Ueki – volume: 17 start-page: 1805 year: 1996 ident: R19-20-20210212 article-title: Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP-3). publication-title: Carcinogenesis doi: 10.1093/carcin/17.9.1805 contributor: fullname: Bian – volume: 14 start-page: 189 year: 1995 ident: R4-20-20210212 article-title: Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas genes. publication-title: Chromosomes Cancer doi: 10.1002/gcc.2870140306 contributor: fullname: Bartsch – volume: 89 start-page: 1260 year: 1997 ident: R17-20-20210212 article-title: Changing views of the role of matrix metalloproteinases in metastasis. publication-title: J Natl Cancer Inst doi: 10.1093/jnci/89.17.1260 contributor: fullname: Chambers – volume: 88 start-page: 1367 year: 2003 ident: R13-20-20210212 article-title: Frequent methylation associated silencing of the tissue inhibitor of metalloproteinase-3 (TIMP-3) gene in pancreatic endocrine tumors. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2002-021027 contributor: fullname: Wild – volume: 59 start-page: 798 year: 1999 ident: R12-20-20210212 article-title: Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. publication-title: Cancer Res contributor: fullname: Bachman – volume: 10 start-page: 2832 year: 2004 ident: R23-20-20210212 article-title: Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinases-7 predicts poor survival. publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-1157-03 contributor: fullname: Jones – volume: 60 start-page: 57 year: 1997 ident: R24-20-20210212 article-title: Autosomal recessive Sorsby fundus dystrophy revisited: molecular evidence for dominant inheritance. publication-title: Am J Hum Genet contributor: fullname: Felbor – volume: 143 start-page: 545 year: 1993 ident: R27-20-20210212 article-title: K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. publication-title: Am J Pathol contributor: fullname: Hruban – volume: 161 start-page: 1015 year: 2002 ident: R20-20-20210212 article-title: Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma. publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)64262-9 contributor: fullname: Lee – volume: 118 start-page: 85 year: 2000 ident: R25-20-20210212 article-title: Autosomal dominant hemorrhagic macular dystrophy not associated with the TIMP3 gene. publication-title: Arch Ophthalmol doi: 10.1001/archopht.118.1.85 contributor: fullname: Ayyagari – volume: 42 start-page: 67 year: 1998 ident: R28-20-20210212 article-title: Ki-ras and p53 gene mutations in pancreatic ductal carcinoma: a relationship with tumor phenotype and survival. publication-title: Eur J Histochem contributor: fullname: Sessa – volume: 50 start-page: 7 year: 2000 ident: R1-20-20210212 article-title: Cancer statistics, 2000. publication-title: CA Cancer J Clin doi: 10.3322/canjclin.50.1.7 contributor: fullname: Greenlee – volume: 93 start-page: 9821 year: 1996 ident: R15-20-20210212 article-title: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.93.18.9821 contributor: fullname: Herman – volume: 157 start-page: 83 year: 2000 ident: R16-20-20210212 article-title: Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)64520-8 contributor: fullname: Heinmoller – volume: 74 start-page: 853 year: 1996 ident: R8-20-20210212 article-title: A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth. publication-title: Biochem Cell Biol doi: 10.1139/o96-090 contributor: fullname: Anand-Apte – volume: 57 start-page: 1731 year: 1997 ident: R3-20-20210212 article-title: Tumor-suppressive pathways in pancreatic carcinoma. publication-title: Cancer Res contributor: fullname: Rozenblum – volume: 88 start-page: 680 year: 1996 ident: R5-20-20210212 article-title: Reduced survival in patients with ductal pancreatic adenocarcinoma associated with CDKN2 mutation. publication-title: J Natl Cancer Inst doi: 10.1093/jnci/88.10.680 contributor: fullname: Bartsch – volume: 79 start-page: 1347 year: 1999 ident: R11-20-20210212 article-title: Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. publication-title: Br J Cancer doi: 10.1038/sj.bjc.6690217 contributor: fullname: Baker – volume: 86 start-page: 5782 year: 2001 ident: R21-20-20210212 article-title: A novel insulinoma tumor suppressor gene locus on chromosome 22q with potential prognostic implications. publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem.86.12.8089 contributor: fullname: Wild – volume: 89 start-page: 1260 year: 1997 ident: R9-20-20210212 article-title: Changing views of the role of matrix metalloproteinases in metastasis. publication-title: J Natl Cancer Inst doi: 10.1093/jnci/89.17.1260 contributor: fullname: Chambers – volume: 74 start-page: 243 year: 2000 ident: R2-20-20210212 article-title: Can we screen high-risk individuals to detect early pancreatic carcinoma? publication-title: J Surg Oncol doi: 10.1002/1096-9098(200008)74:4<243::AID-JSO1>3.0.CO;2-C contributor: fullname: Goggins – volume: 74 start-page: 111 year: 1997 ident: R7-20-20210212 article-title: Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. publication-title: Eur J Cell Biol contributor: fullname: Gomez – volume: 58 start-page: 2310 year: 1998 ident: R10-20-20210212 article-title: Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. publication-title: Cancer Res contributor: fullname: Ahonen – volume: 61 start-page: 249 year: 2001 ident: R26-20-20210212 article-title: Aberrant promoter hypermethylation of multiple genes in non-small cell lung cancers. publication-title: Cancer Res contributor: fullname: Zochbauer-Muller |
| SSID | ssj0017359 |
| Score | 1.8318101 |
| Snippet | Tissue inhibitor of metalloproteinase-3 (TIMP3) antagonizes matrix metalloproteinase activity and can suppress tumor growth, angiogenesis, invasion, and... OBJECTIVESTissue inhibitor of metalloproteinase-3 (TIMP3) antagonizes matrix metalloproteinase activity and can suppress tumor growth, angiogenesis, invasion,... |
| SourceID | proquest crossref pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | e40 |
| SubjectTerms | Adenocarcinoma - metabolism Adenocarcinoma - pathology Aged Aged, 80 and over DNA Methylation Female Gene Expression Regulation, Neoplastic Humans Male Middle Aged Pancreas - enzymology Pancreas - pathology Pancreatic Neoplasms - metabolism Pancreatic Neoplasms - pathology Tissue Inhibitor of Metalloproteinase-3 - genetics Tissue Inhibitor of Metalloproteinase-3 - metabolism |
| Title | Alterations of the tissue inhibitor of metalloproteinase-3 (TIMP3) gene in pancreatic adenocarcinomas |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/15714128 https://search.proquest.com/docview/67439283 |
| Volume | 30 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6lrcQN8SY8feAAqhzZ3rW9PqbUUZDaUlEX9Wbt2mthkTooDyH-PTP7sMOjAg4cYkUrexPNjL-dnflmlpBXgQrrjDNkTzUcjzATPnitwqdchVxGGHbAUPb8Ij274sc5y0cjR-8axv6rpmEMdI2Vs_-g7X5SGIDvoHO4gtbh-ld6ny50n2THb0O_cqOFe9h2n1oJL_DK5NQ3mHLXbRraDpYyn6KzWbw7PcfYK56srNuJAFgYv7I6FABRsPKtqrbrSUXWrT03dw21JKqrAWB1yObjcvF5oABfLIQ9CiTXkZW-vGwOf-Ma0_ZHiatOzFfdumflfBDwm1_F9TdDw-x6ipILWcQDZ2uiHMwmPuO2LNzisM3PtDvbYQOqyjR0suuzMu0nf4F-01I4CCcAo7orJXqyUTxJAJOjCd9Z8FyS_-x9Obs8OSmL_KrYIwcRQBUg5cF0dlwc9ZmolMaZa1aLzT5vnP9Hx-aG3Yr2Woo75LbdbnhTYyd3yUh198itU0uouE_Ujrl4y8YDc_GMuXi9ueD4b8zFe62N5Y2HpgJ3e4OpeD-ZygNyOcuLt3PfnrzhV5TTDXJ2GprxRMg6ziqhREApFyqNG1FJ1jQhfEQgYfsa8QZ7NtKa41GFjKWUxaqhD8l-t-zUY-LVsqqrJJZhlkoWyIQHVFHFFGWplAmlY0Kd2MovpsFK2RMjwhKEXQ7CLrWwSy7G5KWTcAl4iEku0anldl1iUU0GPvOYPDKCH2aN05CBO_bkj88-xeiNoxo-I_ub1VY9J3vrevvCmsd3RsuFHQ |
| link.rule.ids | 315,782,786,27933,27934 |
| linkProvider | Ovid |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alterations+of+the+tissue+inhibitor+of+metalloproteinase-3+%28TIMP3%29+gene+in+pancreatic+adenocarcinomas&rft.jtitle=Pancreas&rft.au=Fendrich%2C+Volker&rft.au=Slater%2C+Emily+P&rft.au=Heinm%C3%B6ller%2C+Ernst&rft.au=Ramaswamy%2C+Annette&rft.date=2005-03-01&rft.eissn=1536-4828&rft.volume=30&rft.issue=2&rft.spage=e40&rft.epage=e45&rft_id=info:doi/10.1097%2F01.mpa.0000153325.62192.8a&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0885-3177&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0885-3177&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0885-3177&client=summon |